• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amicus Therapeutics

Amicus Therapeutics

  1. Amicus Therapeutics' Fabry Drug Moves Closer to European Approval

    Amicus Therapeutics' Fabry Drug Moves Closer to European Approval

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.